Abbott obtains CE mark for duo of glucose-ketone monitors

Abbott has secured a CE mark for two of its glucose-ketone sensing systems for diabetic patients. The Libre Duo systems are the first glucose-ketone monitors to reach the diabetes market. Abbott has become the first company to secure a CE mark for a continuous glucose-ketone sensor for diabetic patients. Credit: Abbott via PR Newswire. Medtech giant Abbott has secured a CE mark for two of its glucose-ketone sensing systems for diabetic patients, making the devices the first of their kind to reach this milestone. The biowearables, which are branded as Libre Duo and Libre Duo 10 Day, are built to…

Source: Medical Device Network